drug
Trump gets more credit than Biden for trying to lower drug prices
WASHINGTON — Controlling drug prices has been a priority for the Trump and Biden administrations. Trump is increasingly recognized for his efforts. A new poll by KFF, a health policy nonprofit, shows that 41% of Americans say it is likely that the Trump administration’s policies will reduce the cost of their prescription drugs. Responses were […]
Marty Makary addresses staff concerns about drug voucher program
WASHINGTON — At an employee-led town hall Tuesday, Food and Drug Administration leaders tried to assuage concerns from within and outside staff about a controversial new program aimed at fast-tracking certain drugs. “This pilot is an effort to make our review processes patient-centered,” said Mallika Mundkur, deputy chief medical officer and manager of the new […]
Roche moves obesity drug into pivotal trials after mid-stage success
Andrew Joseph covers health, medicine and the biopharmaceutical industry in Europe. You can reach Andrew on Signal at drawqjoseph.71. Roche plans to launch Phase 3 studies of its lead obesity candidate this quarter after reporting Tuesday that the drug led to significant weight loss in a mid-stage trial. The drug, known as CT-388, caused an […]
Trump decides to demand lower drug prices under Medicare
You’re reading the web edition of DC Diagnosis, STAT’s biweekly newsletter on health and medicine policy and politics. Sign up here to receive it in your inbox on Tuesdays and Thursdays. The NIH director started the Pete & Bobby fitness challenge, but I didn’t see Jay Bhattacharya doing pull-ups. And you can decide what you […]
Eczema drug Kymera succeeds in first trial, could rival Dupixent
Kymera Therapeutics announced Monday that, for the second time this year, it had successfully completed an early trial of a closely watched drug intended to rival Sanofi and Regeneron’s blockbuster treatment Dupixent. The phase 1 BroADen study enrolled 22 patients with moderate to severe eczema (atopic dermatitis), all of whom took Kymera’s investigational pill, KT-621. […]
Trump Administration Joins Medicare Drug Negotiations
WASHINGTON — The Trump administration on Tuesday celebrated drug price reductions it achieved through a program created by Democrats — despite Republicans’ long-standing antipathy toward the policy. The Inflation Reduction Act, a 2022 law supported only by Democrats and signed into law by then-President Biden, allowed the Trump administration to obtain lower prices on 15 […]
Roche suffers another blow as Indian Supreme Court allows sale of generics of its expensive rare disease drug
In a case billed as profiteering against patients, India’s Supreme Court rejected a petition in which Roche sought to stop a generic drugmaker from selling a cheaper version of an expensive rare disease drug. The move comes after a lower court earlier this month upheld a ruling that it would be in the public interest […]
FDA declares Novo Nordisk drug manufacturing plant non-compliant
A troubled contract manufacturing plant in Indiana recently acquired by Novo Nordisk is considered noncompliant with Food and Drug Administration standards, a serious designation that could further delay approval of drugs made at the facility, including some from Scholar Rock and Regeneron Pharmaceuticals. STAT previously reported that an FDA inspection of the plant over the […]
The Board of Directors of Colorado is moving first in the nation, sets the payment limit on Amgen Drug
In a move from the first per country, a panel of Colorado voted to limit state health plans for costly arthritis treatment, a step that can encourage other states to pursue similar strategies to contain expenditure on prescription medication. The historic vote by the Colorado prescription Drug Approvality Board creates a higher payment limit for […]
The British patient advocates the antitrust regulator to probe drug manufacturers
The UK antitrust regulator was invited by patient defense groups to investigate several major drug manufacturers and their British lobbying organization for “suspects” and “coordinated” efforts to increase the prices of medicines. The backdrop of the complaint was an ongoing row between the pharmaceutical industry and the British government for the compulsory discounts that pharmaceutical […]